Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 20:00
Twist Bioscience Net Income (Quarterly) : -35.05M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.05M |
| March 31, 2026 | -44.02M |
| December 31, 2025 | -30.51M |
| September 30, 2025 | -27.14M |
| June 30, 2025 | 20.39M |
| March 31, 2025 | -39.33M |
| December 31, 2024 | -31.59M |
| September 30, 2024 | -34.66M |
| June 30, 2024 | -85.57M |
| March 31, 2024 | -45.49M |
| December 31, 2023 | -43.01M |
| September 30, 2023 | -46.24M |
| June 30, 2023 | -57.40M |
| March 31, 2023 | -59.16M |
| December 31, 2022 | -41.82M |
| September 30, 2022 | -51.12M |
| June 30, 2022 | -60.52M |
| March 31, 2022 | -60.67M |
| December 31, 2021 | -45.56M |
| September 30, 2021 | -41.24M |
| Date | Value |
|---|---|
| June 30, 2021 | -40.04M |
| March 31, 2021 | -37.92M |
| December 31, 2020 | -32.90M |
| September 30, 2020 | -24.32M |
| June 30, 2020 | -28.21M |
| March 31, 2020 | -31.77M |
| December 31, 2019 | -55.64M |
| September 30, 2019 | -31.18M |
| June 30, 2019 | -27.92M |
| March 31, 2019 | -25.93M |
| December 31, 2018 | -22.64M |
| September 30, 2018 | -19.80M |
| June 30, 2018 | -17.62M |
| March 31, 2018 | -16.87M |
| December 31, 2017 | -16.94M |
| September 30, 2017 | -17.01M |
| June 30, 2017 | -14.32M |
| March 31, 2017 | -14.45M |
| December 31, 2016 | -13.54M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -122.68M |
| Prime Medicine, Inc. | -42.11M |
| Intellia Therapeutics, Inc. | -106.63M |
| 10X Genomics, Inc. | -17.93M |
| Generate Biomedicines, Inc. | -67.26M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 118.38M |
| Total Expenses (Quarterly) | 153.43M |
| EPS Diluted (Quarterly) | -0.5617 |
| Enterprise Value | 9.051B |
| Gross Profit Margin (Quarterly) | 52.76% |
| Profit Margin (Quarterly) | -29.61% |
| Earnings Yield | -1.58% |
| Normalized Earnings Yield | -1.522 |